Stock listing
SLZ0 Stock Price, News, Filings & Events — Enveric Biosciences, Inc.
Selected listing: SLZ0 · GETTEX · EUR · DE
This page tracks Enveric Biosciences, Inc.'s SLZ0:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLZ0:GETTEX. SLZ0:GETTEX is the stock-level entry point for investors researching Enveric Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. With a market capitalization of approximately $4.75 million, Enveric is dedicated to advancing its research in the biosciences sector. The company aims to address unmet medical needs through its specialized approach.

- Ticker
- SLZ0:GETTEX
- Asset type
- Stock
- Market cap
- $6.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- GETTEX
- Currency
- EUR
Enveric Biosciences, Inc. SLZ0:GETTEX stock context
This page tracks Enveric Biosciences, Inc.'s SLZ0:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLZ0:GETTEX. SLZ0:GETTEX is the stock-level entry point for investors researching Enveric Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. With a market capitalization of approximately $4.75 million, Enveric is dedicated to advancing its research in the biosciences sector. The company aims to address unmet medical needs through its specialized approach.
Latest news from Enveric Biosciences, Inc.
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 1, 2026
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
July 28, 2026
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
June 29, 2026
Enveric Biosciences Announces Participation in 2026 BIO International Convention
June 16, 2026
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day
June 9, 2026
Research Enveric Biosciences, Inc.
Enveric Biosciences, Inc. investor report
Review AI stock analysis and investor report context for SLZ0:GETTEX.
Enveric Biosciences, Inc. company profile
View the public company page for Enveric Biosciences, Inc. on 6ix.
Enveric Biosciences, Inc. news
Read company news and market updates connected to Enveric Biosciences, Inc..
Enveric Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Enveric Biosciences, Inc..
Alternate listings
ENVB:NASDAQ
US · USD
Alternate listing for Enveric Biosciences, Inc.; the primary context on this page is SLZ0:GETTEX.
ENVB:BOATS
US · USD
Alternate listing for Enveric Biosciences, Inc.; the primary context on this page is SLZ0:GETTEX.
SLZ0:FWB
DE · EUR
Alternate listing for Enveric Biosciences, Inc.; the primary context on this page is SLZ0:GETTEX.
SLZ0:MUN
DE · EUR
Alternate listing for Enveric Biosciences, Inc.; the primary context on this page is SLZ0:GETTEX.
SLZ:SWB
DE · EUR
Alternate listing for Enveric Biosciences, Inc.; the primary context on this page is SLZ0:GETTEX.